SEARCH   
MEMBER LOGIN    

Pharmaceutical Product Manufacturing in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Pharmaceutical Product Manufacturing Market Research Report | ANZSIC C1841 | Nov 2014

Side effects: Industry revenue falls as the era of the blockbuster drug nears its end

IBISWorld’s Pharmaceutical Product Manufacturing market research report is a comprehensive guide to market size and growth prospects. Our industry reports offer strategic industry analysis of the factors influencing companies, including new product developments, economic, lifestyle and demographic influences, distribution and supply chain factors and pricing issues. Full analysis accompanies our data forecasts to illustrate how the market responds to emerging industry trends.

Report Snapshot
Industry Statistics & Market Size
Revenue
$9bn
Annual Growth 10-15
-2.7%
Annual Growth 15-20
Add to Cart
Profit
Add to Cart
Employment
14,200
Businesses
292
Industry Analysis & Industry Trends

The Pharmaceutical Product Manufacturing industry is dominated by major global pharmaceutical groups, although only a small number are engaged in local manufacture of active pharmaceutical ingredients. An increasing number of firms are limiting their Australian involvement to the later stages of the manufacturing process, such as dispensing, packaging and the fill-and-finish stage. A large number of players also restrict their Australian activities to purely distribution.

As with the global pharmaceutical industry, the local industry is currently contending with the fallout associated with the patent cliff. Between 2011 and 2015, some of the world's highest selling drugs have already lost or are due to lose patent protection... purchase to read more

Industry Report - Industry Investment Chapter

The Pharmaceutical Product Manufacturing industry has a medium level of capital intensity, reflecting the level of capital tied up in manufacturing facilities capable of producing, high-cost, high-technology drugs. In 2014-15, for every dollar that the overall industry spends on capital, $7.80 is spent on wages. Capital labour intensity ratios vary between product segments, with the patented prescription product segment having a considerably higher ratio than the generic and OTC product segments.

Falling levels of capital investment growth have recently characterised the industry, with fewer players investing in updating manufacturing capacity or equipment... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Pharmaceutical Product Manufacturing Industry?

The industry comprises companies that manufacture various medicinal and pharmaceutical products for human use from both synthetic (chemical) and natural sources. Other products include chemical or diagnostic testing agents, blood serums and biotech products. Manufacturing activities include the manufacture of active pharmaceutical ingredients and synthesis of chemical ingredients, through to late-stage packaging and fill-finish activities.

Industry Products
Patented prescription pharmaceuticalsOTC and complementary medicinesGeneric prescription pharmaceuticals
 
Industry Activities
Antibacterial, antibiotic and antitoxinVaccineVitamin productHerbal drugAmpoule, medicinal capsule, medicinal ointment and vialBiotechnological pharmaceutical and medicinal productsSerum and blood serumDiagnostic substance


View Sample
Quote
Select Clients